Accession Number: | 0001628280-23-018557 |
Date: | 2023-05-15 |
Issuer: | AVALO THERAPEUTICS, INC. (AVTX) |
Original Submission Date: |
SULLIVAN CHRISTOPHER RYAN
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE, MD 20850
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.75 | 2023-05-15 | deemed execution date | A | 40,000 (a) | 2024-05-15 | 2033-05-15 | common stock 40,000 | $2.75 | 40,000 | direct |
ID | footnote |
---|---|
f1 | the stock option will vest in full on may 15, 2024, subject to the reporting person's continued service on such vesting date. |